17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Virtual Reality
University of Maryland, BaltimoreSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Virtual Reality cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE IRCCS San Raffaele | N/A | D |
DEXKETOPROFEN IRCCS San Raffaele | N/A | D |
METAMIZOLE IRCCS San Raffaele | N/A | D |
PANITUMUMAB Heinrich-Heine University, Duesseldorf | N/A | D |
Same molecule, other indications
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →